Omotola Watkins, Author at Clinical Trials Portal

Tropion 05

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator’s Choice of Chemotherapy in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer

NSABP B-64

EXActDNA-003 / NSABP B-64:Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

NRG-GI008

Using cancer cells in the blood (ctDNA) to determine the type of chemotherapy that will benefit patients who have had surgery for colon cancer

NRG-CC011

COGNITIVE TRAINING FOR CANCER RELATED COGNITIVE IMPAIRMENT IN BREAST CANCER SURVIVORS: A MULTI-CENTER RANDOMIZED DOUBLE- BLINDED CONTROLLED TRIAL

EAQ222CD

Effectiveness of Out-of-Pocket Cost COMmunication and Financial Navigation (CostCOM) in Cancer Patients

CAMBRIA-2

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer

NRG-GU008

Testing the addition of the drug apalutamide to the usual hormone therapy and radiation therapy after surgery for prostate cancer

EAQ221CD

Mobile Health for Adherence in Breast Cancer Patients

S2302

Non-Chemotherapy Treatment (ramucirumab plus pembrolizumab) or Usual Care for Advanced Non-Small Cell Lung Cancer Following Immunotherapy

R3767-ONC-2236

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer